内质网-线粒体接触位点是连接小鼠肠道L细胞营养感知与GLP-1分泌的信号枢纽:从生理学到肥胖和2型糖尿病
该研究探讨内质网-线粒体接触位点(MAMs)在肠道L细胞营养诱导的GLP-1分泌中的作用。研究采用STC-1细胞、小鼠回肠类器官和体内Glu-Venus小鼠,发现葡萄糖和脱氧胆酸动态增强MAMs并促进GLP-1释放,而肥胖削弱该反应。结论提示MAMs是GLP-1分泌调控的新靶点,在肥胖和2型糖尿病中受损。
要点
- 葡萄糖和脱氧胆酸通过不同机制动态增强L细胞MAMs,进而促进GLP-1分泌。
- 药理学或遗传学破坏MAMs可阻断L细胞对葡萄糖和脱氧胆酸的分泌反应。
- 饮食诱导肥胖增强基础MAMs但阻断口服葡萄糖诱导的GLP-1分泌和MAM上调。
核心结论
- 内质网-线粒体钙偶联在葡萄糖诱导的肠道L细胞GLP-1分泌中起新作用,且在肥胖和2型糖尿病中受损,提示MAMs可作为调节GLP-1分泌的新靶点。
研究设计与样本
- 研究结合生化与成像方法,在STC-1细胞系、离体小鼠回肠类器官以及Glu-Venus小鼠体内肠道内分泌细胞中,检测营养诱导的GLP-1分泌及内质网-线粒体相互作用和钙交换,涵盖急性条件及饮食诱导肥胖和2型糖尿病后。
主要发现
- 葡萄糖和脱氧胆酸(DCA)在STC-1细胞中分别诱导内质网-线粒体相互作用增强1.8倍和2.1倍。
- 在离体小鼠回肠类器官中,葡萄糖和DCA分别诱导内质网-线粒体相互作用增强1.7倍和1.3倍。
- 在Glu-Venus小鼠体内结肠L细胞中,葡萄糖和DCA分别诱导内质网-线粒体相互作用增强1.3倍和1.2倍。
- 葡萄糖增加STC-1细胞中内质网-线粒体钙交换1.2倍,且分泌的GLP-1通过旁分泌作用参与调节MAMs。
- 耗竭内质网钙或抑制线粒体钙进入分别降低葡萄糖诱导的GLP-1分泌37.5%和30.9%,诱导内质网或线粒体应激则分别阻止其分泌47.9%和51.8%。
关键数值与推荐
- 药理学和遗传学破坏细胞器通讯均阻断STC-1细胞对葡萄糖和DCA的分泌反应。
- 葡萄糖通过钠-葡萄糖协同转运蛋白1介导的生电效应诱导内质网-线粒体通讯,而DCA通过TGR5-cAMP-PKA通路起作用。
临床怎么用
- 靶向MAMs可能成为改善代谢疾病中GLP-1分泌和血糖结局的新策略,尤其在肥胖和2型糖尿病中MAMs反应性受损的情况下。
局限性
- 研究主要基于小鼠细胞系、类器官和动物模型,尚未在人类肠道L细胞或临床人群中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Postprandial glucagon-like peptide-1 (GLP-1) secretion by enteroendocrine L cells of the gut plays an important role in glucose homeostasis, thus representing a therapeutic option of ever-growing significance for type 2 diabetes. However, the precise mechanisms linking nutrient sensing and GLP-1 secretion are incompletely understood. In this study, we focused on a potential new role for endoplasmic reticulum (ER)-mitochondria contact sites, called mitochondria-associated membranes (MAMs), in nutrient-induced GLP-1 secretion by L cells, as they are dynamically regulated by nutrients, they influence cellular calcium homeostasis crucial for hormone secretion, and their miscommunication has been implicated in alterations of glucose homeostasis in several tissues. METHODS: We combined biochemical and imaging approaches to investigate nutrient-induced GLP-1 secretion, and ER-mitochondria interaction and calcium exchange in the STC-1 cell line, ex vivo ileal mouse organoids, and/or in vivo in gut enteroendocrine cells from Glu-Venus mice, both in acute conditions and after diet-induced obesity and type 2 diabetes. RESULTS: We show here that ER-mitochondria interactions are dynamically induced by two GLP-1 secretagogues, glucose and deoxycholic acid (DCA), in STC-1 cells (1.8- and 2.1-fold, respectively), ileal mouse organoids (1.7- and 1.3-fold, respectively), and in vivo in colonic L cells of Glu-Venus mice (1.3- and 1.2-fold, respectively). In addition, glucose increased ER-mitochondria calcium exchange in STC-1 cells (1.2-fold). A paracrine action of secreted GLP-1 was also involved in the regulation of MAMs by glucose and DCA in STC-1 cells. Dynamic reinforcement of MAMs by glucose and DCA played a causal role in GLP-1 release, as both pharmacological and genetic disruption of organelle communication blocked L cell secretory response to the two stimuli in STC-1 cells. In agreement, depleting ER calcium levels or inhibiting mitochondrial calcium entry decreased glucose-induced GLP-1 secretion (-37.5% and -30.9%, respectively), whereas inducing ER or mitochondrial stress prevented it (-47.9% and -51.8%, respectively). Mechanistically, glucose induces ER-mitochondria communication through a sodium-glucose cotransporter 1-mediated electrogenic effect, whereas DCA acts through a Takeda G protein-coupled receptor 5 (TGR5)-cAMP-protein kinase A (PKA) pathway. Finally, we demonstrated in C57Bl/6J mice and in Glu-Venus mice that diet-induced obesity reinforced basal ER-mitochondria interactions in colonic L cells and blocked their ability to respond to oral glucose in terms of both GLP-1 secretion and MAM upregulation. CONCLUSIONS/INTERPRETATION: These results point to a new role for ER-mitochondria calcium coupling in glucose-induced GLP-1 secretion in L cells of the gut, which is impaired in obesity and type 2 diabetes, providing a novel target for the modulation of GLP-1 secretion. Therefore, these data reinforce the potential targeting of MAMs to improve glycaemic outcomes in metabolic diseases.
引用
- Humbert A, Nawrot M, Bendridi N, et al. Endoplasmic reticulum-mitochondria contact sites are signalling hubs connecting nutrient sensing and GLP-1 secretion in L cells of the mouse gut: from physiology to obesity and type 2 diabetes. Diabetologia. 2026. PMID: 41795036. doi:10.1007/s00125-026-06693-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。